Improving AAV Production Yield and Quality for Different Serotypes Using Distinct Processing Methods
ACS Omega · 10.06.2025 · 10 (22) · 22657-22670
DOI: 10.1021/acsomega.4c10900 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 31.05.2025. Verfasst von Ashish Khaparde und 4 weiteren Autor:innen. Beteiligte Einrichtung: GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore 560099, India. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust DBT India Alliance, Narayana Nethralaya Foundation.
Abstract (Originalsprache)
Adeno-associated viruses (AAVs) have emerged as a promising tool for gene therapy due to their excellent safety profile and efficient transduction in multiple target tissues. Currently generated AAV yields at lab scale are in the range of 1012-1014 vgc/L or between 104 and 105 vg/cell. Maximizing yields would significantly impact the overall production cost and accessibility. However, existing challenges to improving the overall yield from upstream and downstream processes persist. Using an adherent cell manufacturing process, we compared two different purification approaches to optimize the recovery from cell lysate (CsCl ultracentrifugation) and media supernatant (affinity column chromatography). We achieved combined purified yields of 2.25 × 1013 for AAV6 (1.00 × 1013 (44.44%) from ultracentrifugation and 1.25 × 1013 (55.56%) from affinity chromatography), 1.11 × 1014 for AAV8 (2.37 × 1013 (21.39%) from ultracentrifugation and 8.70 × 1013 (78.61%) from affinity chromatography), and 7.32 × 1013 for AAV9 (1.10 × 1013 (15.03%) from ultracentrifugation and 6.22 × 1013 (84.97%) from affinity chromatography), with AAV9 showing a ∼1.5-fold increase compared to previous reports. Interestingly, we found each serotype to elute at different pH values which may influence yields. The chromatography approach obtained higher percentage recoveries for AAV6 (88.35 ± 12.87%), AAV8 (96.67 ± 0.60%), and AAV9 (93.54 ± 1.08%) from the media supernatant and also demonstrated significantly higher transduction rates. Thus, we demonstrate the potential for further expanding the AAV production capacity while also improving the final product quality.
Autor:innen und Institutionen
- GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore 560099, India.
- Manipal Academy of Higher Education, Manipal 576104, India.
ORCID-Profile: Ashish Khaparde, Arkasubhra Ghosh
Förderung
- Wellcome Trust DBT India Alliance
- Narayana Nethralaya Foundation
Zitieren
APA
Khaparde, A., Patra, R., Roy, S., Babu G R, S., & Ghosh, A. (2025). Improving AAV Production Yield and Quality for Different Serotypes Using Distinct Processing Methods. ACS Omega, 10(22), 22657-22670. https://doi.org/10.1021/acsomega.4c10900
Vancouver
Khaparde A, Patra R, Roy S, Babu G R S, Ghosh A. Improving AAV Production Yield and Quality for Different Serotypes Using Distinct Processing Methods. ACS Omega. 2025;10(22):22657-22670. doi:10.1021/acsomega.4c10900
BibTeX
@article{Khaparde2025,
author = {Khaparde, Ashish and Patra, Riya and Roy, Shomereeta and Babu G R, Sharath and Ghosh, Arkasubhra},
title = {Improving AAV Production Yield and Quality for Different Serotypes Using Distinct Processing Methods},
journal = {ACS Omega},
year = {2025},
volume = {10},
number = {22},
pages = {22657--22670},
doi = {10.1021/acsomega.4c10900}
}
EUVIMED